PATENT CLAIM ANALYSIS

Application Number: 15933739
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting PCSK9 expression, which may be useful for treating, preventing, or ameliorating a disease associated with PCSK9.

Claim (Index 16):
The compound of  claim 15 , wherein the bicyclic sugar is selected from the group consisting of: 4\u2032-(CH 2 )\u2014O-2\u2032 (LNA); 4\u2032-(CH 2 ) 2 \u2014O-2\u2032 (ENA); and 4\u2032-CH(CH 3 )\u2014O-2\u2032 (cEt).

Metadata:
- Claim Count in Document: 68.0
- Percentile: 90.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12478488', '14959714', '14149715', '14839580', '14701999']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8287158186022271
- 35 USC 102 Novelty (BERT): 0.5295229433025148
- Combined Prediction Score: 0.7987965310722559
- Mean Citation Score: 352.086664
- Max Citation Score: 362.38525
- Similarity Product: 257.2869749712944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test